Last updated on April 2018

Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia


Brief description of study

Adjunctive Therapy of AndrographolidSulfonate in Community Acquired Pneumonia: A Multicenter, Randomized,Double-blinded, Placebo Controlled Clinical Trial. The hypothesis is that combination therapy with Andrographolid Sulfonatein injection and antibacterial is significantly better than antibacterial alone in achieving clinical stability among hospitalized CAP patients.

Clinical Study Identifier: NCT02913118

Find a site near you

Start Over